← Eichor
Study identifier: NCT06688396 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)

Condition: Dilated Cardiomyopathy · Heart Failure · Heart Disease  ·  Sponsor: Lancaster General Hospital

PhaseNA
Planned participants150
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

This is a prospective, single-arm clinical trial in which participants with dilated cardiomyopathy will invite their first degree relatives to undergo mobile cardiac, electrocardiogram screening.

This description comes directly from the study's public registry record.

Talk to the study team

Halle Becker, MPH  ·  717-544-1777  ·  Halle.Becker@pennmedicine.upenn.edu

Jonathan Derr, MBA  ·  717-544-1777  ·  Jonathan.Derr@pennmedicine.upenn.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Lancaster General HospitalLancaster, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06688396